Exit Completed: company sold its business/assets or its part of the business to a local partner and leaved the market or liquidated local entity(ies)
Exited Exit CompletedAmbu, or officially Ambu A/S, is a Danish company that develops, produces and markets single-use endoscopy solutions, diagnostic and life-supporting equipment to hospitals, private practices, and rescue services. It was founded in Denmark in 1937, as Testa Laboratorium, by German engineer Holger Hesse.
Exit Completed: company sold its business/assets or its part of the business to a local partner and leaved the market or liquidated local entity(ies)
Exited Exit CompletedIt’s a legal battle for pharmaceutical company Ambu to liquidate its subsidiary in Russia, but CEO Britt Meelby Jensen remains confident that it will be accomplished before the New Year (2024). "Ambu is in the process of formally liquidating our Russian subsidiary. We did not sell or promote any products in Russia during the 2023/24 financial year, and we have no plans to do so in the future," the company said in its annual report. 10.07.2025: The legal entity AMBU LLC was liquidated.
| July 28, 2025 | Ambu liquidates Russian subsidiary |
| September 05, 2024 | Ambu maintains goal of Russian exit in 2024: “We are de facto out of Russia” |
| September 05, 2024 | LLC "AMBU" - Moscow - General Director Sorokin S. V. – TIN 9706000440 |
| January 24, 2023 | Ambu annual report 2023/24 |